In the world of scientific research, collaboration is often the key to groundbreaking discoveries. This is precisely what Drs. Hanna Brauner and Nikolas Herold, two clinical researchers with a shared interest in cancer biology, have demonstrated through their work at the Karolinska Institutet's Research Incubator (KIRI).
The Power of Interdisciplinary Partnerships
Drs. Brauner and Herold, a dermatologist and a paediatrician respectively, found a unique synergy in their collaboration. Dr. Herold's expertise in drug resistance factors and immunological processes in tumours complemented Dr. Brauner's focus on natural killer (NK) cells and skin lymphoma. This partnership allowed them to explore the impact of the enzyme SAMHD1 on immune cells in skin lymphoma, a disease that affects approximately 100 people in Sweden annually and lacks effective treatments.
Unpredictable Results, Exciting Discoveries
The results of their project, which are awaiting publication, offer new potential therapies. One finding suggests activating NK cells locally to combat lymphoma, while another reveals a combination of existing drugs that can overcome the drug suppressive effect of SAMHD1. Dr. Herold's excitement is palpable when he describes the moment they realized, "Wow, this drug makes SAMHD1 disappear!"
The Value of a Collaborative Environment
KIRI, a platform designed to foster interdisciplinary partnerships, played a crucial role in facilitating this collaboration. Dr. Herold emphasizes the importance of the social aspect, noting the value of meeting over pizza and wine at the faculty club. These casual interactions create an environment conducive to open conversation, not just about research but also about the challenges of grant applications and personal matters.
A Productive Dynamic
Dr. Brauner and Dr. Herold's collaboration has been a productive one, despite their different approaches. Dr. Herold describes Dr. Brauner as "wise and thoughtful," while he admits to being more impulsive. This dynamic, they agree, has been very productive. Both researchers appreciate the equality of their shared leadership, a dynamic that better reflects the real-world dynamics of collaboration outside academia.
The Impact of KIRI
Since its launch in 2022, KIRI has grown significantly, now boasting over 80 Fellows, 20 active postdocs, and 28 different interdisciplinary research projects. This growth underscores the value of platforms like KIRI in fostering innovative research and collaboration. As Dr. Brauner notes, "KIRI isn't just about the postdoc project; it's about bringing different research fields and departments together, creating added value."
Conclusion
The story of Drs. Brauner and Herold's collaboration is a testament to the power of interdisciplinary partnerships and the unexpected discoveries that can arise from them. Their work highlights the importance of platforms like KIRI in fostering an environment where ideas can flourish and where the best ideas have the greatest chance of winning.
